Body mass index and survival of patients with lymphoma

The impact of body mass index (BMI) on survival in lymphoma remains controversial. We leveraged a prospective cohort of lymphoma patients enrolled to SPORE Molecular Epidemiology Resource between 2002 and 2015 to assess the association of BMI before diagnosis, BMI at diagnosis, and BMI change over t...

Full description

Saved in:
Bibliographic Details
Published in:Leukemia & lymphoma 2021-09, Vol.62 (11), p.2671-2678
Main Authors: Chihara, Dai, Larson, Melissa C., Robinson, Dennis P., Thompson, Carrie A., Maurer, Matthew J., Casulo, Carla, Pophali, Priyanka, Link, Brian K., Habermann, Thomas M., Feldman, Andrew L., Flowers, Christopher R., Cerhan, James R., Morton, Lindsay M.
Format: Article
Language:English
Subjects:
Body Mass Index
CLL/SLL
Cohort Studies
Diffuse large B-cell lymphoma
follicular lymphoma
Humans
Leukemia, Lymphocytic, Chronic, B-Cell - diagnosis
Leukemia, Lymphocytic, Chronic, B-Cell - epidemiology
Lymphoma, Follicular - diagnosis
Lymphoma, Follicular - epidemiology
Lymphoma, Large B-Cell, Diffuse - diagnosis
Lymphoma, Large B-Cell, Diffuse - epidemiology
Prospective Studies
survival
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The impact of body mass index (BMI) on survival in lymphoma remains controversial. We leveraged a prospective cohort of lymphoma patients enrolled to SPORE Molecular Epidemiology Resource between 2002 and 2015 to assess the association of BMI before diagnosis, BMI at diagnosis, and BMI change over time with lymphoma-specific survival (LSS). A total of 4009 lymphoma patients (670 diffuse large B-cell lymphoma (DLBCL), 689 follicular lymphoma (FL), 1018 chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), and 1632 other subtypes) were included. Significantly shorter LSS after diagnosis was observed for FL patients who were obese before diagnosis (HR: 3.02, 95%CI: 1.43-6.41, p=.004) and for those with a ≥ 5% increase in BMI from diagnosis to 3-year follow-up (HR: 3.53, 95%CI: 1.22-10.2, p=.020). In contrast, obesity prior to or at the time of diagnosis was not associated with LSS in DLBCL and CLL/SLL. The impact of weight control after diagnosis in FL patient warrants investigation.
ISSN:1042-8194
1029-2403
DOI:10.1080/10428194.2021.1929956